We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
Cap. Flow
-$2.03B
Cap. Flow %
-2.75%
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$60.7M
2
ADI icon
Analog Devices
ADI
+$46.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37.3M
4
MTCH icon
Match Group
MTCH
+$28.2M
5
GXO icon
GXO Logistics
GXO
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 23.91%
2 Financials 14.2%
3 Healthcare 13.07%
4 Consumer Discretionary 12.09%
5 Communication Services 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DT icon
826
Dynatrace
DT
$14.2B
$12.7M 0.02%
179,444
+4,081
+2% +$268K
HIW icon
827
Highwoods Properties
HIW
$3.47B
$12.7M 0.02%
289,910
-10,655
-4% -$488K
DISCK
828
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$12.7M 0.02%
523,419
+12,460
+2% +$333K
BAH icon
829
Booz Allen Hamilton
BAH
$9.15B
$12.7M 0.02%
160,069
+6,429
+4% +$537K
PLUG icon
830
Plug Power
PLUG
$3.04B
$12.7M 0.02%
497,232
-793
-0.2% -$21.2K
VNO icon
831
Vornado Realty Trust
VNO
$7.38B
$12.7M 0.02%
302,174
-5,340
-2% -$230K
DOC
832
DELISTED
PHYSICIANS REALTY TRUST
DOC
$12.7M 0.02%
720,267
+8,321
+1% +$154K
ETRN
833
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$12.7M 0.02%
1,250,730
+9,602
+0.8% +$84.7K
TAP icon
834
Molson Coors Class B
TAP
$8.1B
$12.7M 0.02%
272,981
-5,157
-2% -$252K
PK icon
835
Park Hotels & Resorts
PK
$2.97B
$12.6M 0.02%
660,681
-20,612
-3% -$389K
CXT icon
836
Crane NXT
CXT
$3.07B
$12.6M 0.02%
383,621
-15,832
-4% -$527K
SSNC icon
837
SS&C Technologies
SSNC
$18.6B
$12.6M 0.02%
181,171
-35,361
-16% -$2.62M
STL
838
DELISTED
Sterling Bancorp
STL
$12.6M 0.02%
503,109
-18,666
-4% -$423K
OGN icon
839
Organon & Co
OGN
$3.57B
$12.5M 0.02%
381,235
-3,684
-1% -$118K
JBLU icon
840
JetBlue
JBLU
$2.29B
$12.5M 0.02%
817,430
-26,238
-3% -$403K
MAC icon
841
Macerich
MAC
$6.92B
$12.5M 0.02%
747,424
+109,772
+17% +$1.86M
ICUI icon
842
ICU Medical
ICUI
$4.61B
$12.4M 0.02%
53,315
-1,451
-3% -$304K
IBKR icon
843
Interactive Brokers
IBKR
$39.6B
$12.4M 0.02%
795,160
+12,148
+2% +$191K
AMED
844
DELISTED
Amedisys
AMED
$12.4M 0.02%
82,997
-540
-0.6% -$112K
CRUS icon
845
Cirrus Logic
CRUS
$6.26B
$12.4M 0.02%
150,188
-4,943
-3% -$411K
NFG icon
846
National Fuel Gas
NFG
$7.65B
$12.4M 0.02%
235,357
-8,208
-3% -$425K
FLS icon
847
Flowserve
FLS
$10.2B
$12.3M 0.02%
355,995
-12,911
-3% -$505K
CC icon
848
Chemours
CC
$2.37B
$12.3M 0.02%
422,654
-11,067
-3% -$358K
CPB icon
849
Campbell Soup
CPB
$6.87B
$12.2M 0.02%
292,231
-16,556
-5% -$719K
PBCT
850
DELISTED
People's United Financial Inc
PBCT
$12.2M 0.02%
699,275
-14,230
-2% -$231K

Similar funds

RhumbLine Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
  • RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
  • RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
  • RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
  • RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
  • RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.

Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.